Pharma Commercial Mock
← All views

#heor-evidence

RWE, budget impact, dossier updates

C07HEOR09
319 msgs in channel · showing recent 250 + 2 storyline
KW
Karen WuWed Jul 9, 3:34 PM
Updated BIM v3 attached. Reviewed by health econ team.
VI
Vikram IyerWed Jul 9, 6:45 PM
Updated BIM v4 attached. Reviewed by health econ team.
VI
Vikram IyerFri Jul 10, 9:04 PM
RWE cohort n=5; durability extrapolation looks consistent.
KW
Karen WuFri Jul 10, 9:46 PM
ITC analysis vs Merck — final tables in the dossier folder.
VI
Vikram IyerTue Jul 15, 3:13 PM
PRO data pull complete — 79 patients with EQ-5D-5L at week 72.
SL
Sara LindqvistTue Jul 15, 6:45 PM
Updated BIM v4 attached. Reviewed by health econ team.
VI
Vikram IyerWed Jul 16, 12:39 PM
Module B drafted — sending for internal review.
VI
Vikram IyerThu Jul 16, 9:56 PM
ICER white paper draft v5 — comments by Friday please.
KW
Karen WuSun Jul 20, 2:09 PM
Module B drafted — sending for internal review.
VI
Vikram IyerMon Jul 21, 2:40 PM
Engaged Optum data team on the Q2 pull.
VI
Vikram IyerTue Jul 22, 1:23 PM
Cost-effectiveness model PSA convergence good at 64 runs.
VI
Vikram IyerTue Jul 22, 3:04 PM
Cost-effectiveness model PSA convergence good at 62 runs.
SL
Sara LindqvistTue Jul 22, 5:51 PM
Updated BIM v4 attached. Reviewed by health econ team.
VI
Vikram IyerThu Jul 24, 3:56 PM
Updated BIM v4 attached. Reviewed by health econ team.
VI
Vikram IyerFri Jul 25, 4:53 PM
RWE cohort n=56; durability extrapolation looks consistent.
SL
Sara LindqvistSat Jul 26, 3:23 PM
ICER white paper draft v1 — comments by Friday please.
VI
Vikram IyerWed Jul 30, 5:21 PM
RWE cohort n=65; durability extrapolation looks consistent.
VI
Vikram IyerFri Aug 1, 6:56 PM
NICE submission timeline locked. Module B due 6/15.
VI
Vikram IyerSat Aug 2, 3:38 PM
RWE cohort n=48; durability extrapolation looks consistent.
SL
Sara LindqvistSat Aug 2, 7:29 PM
NICE submission timeline locked. Module B due 6/15.
SL
Sara LindqvistMon Aug 3, 9:27 PM
Updated BIM v4 attached. Reviewed by health econ team.
SL
Sara LindqvistWed Aug 6, 12:58 PM
Module B drafted — sending for internal review.
VI
Vikram IyerThu Aug 7, 1:35 PM
ICER white paper draft v5 — comments by Friday please.
SL
Sara LindqvistSat Aug 8, 8:04 PM
RWE cohort n=10; durability extrapolation looks consistent.
VI
Vikram IyerSun Aug 9, 9:30 PM
Updated BIM v1 attached. Reviewed by health econ team.
KW
Karen WuTue Aug 12, 12:28 PM
Cost-effectiveness model PSA convergence good at 40 runs.
KW
Karen WuTue Aug 12, 2:50 PM
ICER white paper draft v2 — comments by Friday please.
SL
Sara LindqvistThu Aug 13, 9:57 PM
Cost-effectiveness model PSA convergence good at 72 runs.
VI
Vikram IyerFri Aug 15, 12:32 PM
ICER white paper draft v4 — comments by Friday please.
VI
Vikram IyerWed Aug 20, 7:29 PM
PRO data pull complete — 45 patients with EQ-5D-5L at week 28.
VI
Vikram IyerFri Aug 22, 2:14 PM
ICER white paper draft v3 — comments by Friday please.
SL
Sara LindqvistFri Aug 22, 7:54 PM
Health-econ team meeting moved to Thursday.
SL
Sara LindqvistMon Aug 25, 4:05 PM
Health-econ team meeting moved to Thursday.
KW
Karen WuTue Aug 26, 1:01 PM
Module B drafted — sending for internal review.
VI
Vikram IyerTue Aug 26, 4:19 PM
ICER white paper draft v2 — comments by Friday please.
KW
Karen WuThu Aug 27, 9:28 PM
Engaged Optum data team on the Q2 pull.
VI
Vikram IyerThu Aug 28, 12:09 PM
Module B drafted — sending for internal review.
SL
Sara LindqvistSat Aug 30, 3:15 PM
Cost-effectiveness model PSA convergence good at 35 runs.
KW
Karen WuTue Sep 2, 4:53 PM
ITC analysis vs Merck — final tables in the dossier folder.
SL
Sara LindqvistWed Sep 2, 9:50 PM
RWE cohort n=60; durability extrapolation looks consistent.
KW
Karen WuWed Sep 3, 2:31 PM
ITC analysis vs BMS — final tables in the dossier folder.
SL
Sara LindqvistFri Sep 5, 2:32 PM
Cost-effectiveness model PSA convergence good at 46 runs.
SL
Sara LindqvistFri Sep 5, 4:20 PM
RWE cohort n=41; durability extrapolation looks consistent.
VI
Vikram IyerFri Sep 5, 7:38 PM
Engaged Optum data team on the Q2 pull.
SL
Sara LindqvistTue Sep 9, 7:01 PM
Module B drafted — sending for internal review.
KW
Karen WuThu Sep 10, 9:08 PM
ITC analysis vs AstraZeneca — final tables in the dossier folder.
VI
Vikram IyerThu Sep 10, 9:22 PM
RWE cohort n=82; durability extrapolation looks consistent.
SL
Sara LindqvistSat Sep 12, 8:38 PM
Cost-effectiveness model PSA convergence good at 33 runs.
SL
Sara LindqvistWed Sep 17, 12:56 PM
Updated BIM v4 attached. Reviewed by health econ team.
VI
Vikram IyerWed Sep 17, 6:21 PM
PRO data pull complete — 7 patients with EQ-5D-5L at week 72.
KW
Karen WuThu Sep 18, 4:26 PM
RWE cohort n=40; durability extrapolation looks consistent.
SL
Sara LindqvistSat Sep 19, 8:00 PM
Updated BIM v2 attached. Reviewed by health econ team.
KW
Karen WuSat Sep 20, 4:49 PM
Module B drafted — sending for internal review.
SL
Sara LindqvistSat Sep 20, 6:27 PM
Module B drafted — sending for internal review.
KW
Karen WuTue Sep 23, 2:32 PM
Module B drafted — sending for internal review.
KW
Karen WuWed Sep 23, 8:53 PM
ICER white paper draft v5 — comments by Friday please.
SL
Sara LindqvistThu Sep 25, 1:09 PM
ITC analysis vs Daiichi — final tables in the dossier folder.
SL
Sara LindqvistFri Sep 25, 9:16 PM
Updated BIM v6 attached. Reviewed by health econ team.
SL
Sara LindqvistFri Sep 26, 5:29 PM
ICER white paper draft v1 — comments by Friday please.
SL
Sara LindqvistSat Sep 27, 3:49 PM
ITC analysis vs AstraZeneca — final tables in the dossier folder.
SL
Sara LindqvistTue Sep 30, 5:53 PM
NICE submission timeline locked. Module B due 6/15.
SL
Sara LindqvistThu Oct 2, 4:39 PM
PRO data pull complete — 36 patients with EQ-5D-5L at week 60.
SL
Sara LindqvistFri Oct 3, 1:19 PM
Cost-effectiveness model PSA convergence good at 70 runs.
VI
Vikram IyerFri Oct 3, 4:43 PM
Health-econ team meeting moved to Thursday.
VI
Vikram IyerTue Oct 7, 12:57 PM
ITC analysis vs AstraZeneca — final tables in the dossier folder.
SL
Sara LindqvistThu Oct 9, 1:38 PM
Cost-effectiveness model PSA convergence good at 76 runs.
KW
Karen WuThu Oct 9, 3:16 PM
Cost-effectiveness model PSA convergence good at 84 runs.
SL
Sara LindqvistFri Oct 10, 1:08 PM
Updated BIM v4 attached. Reviewed by health econ team.
SL
Sara LindqvistFri Oct 10, 5:50 PM
ICER white paper draft v4 — comments by Friday please.
VI
Vikram IyerSat Oct 11, 12:03 PM
Health-econ team meeting moved to Thursday.
SL
Sara LindqvistWed Oct 15, 4:04 PM
Engaged Optum data team on the Q3 pull.
KW
Karen WuThu Oct 16, 6:09 PM
Module B drafted — sending for internal review.
VI
Vikram IyerSat Oct 18, 1:02 PM
Updated BIM v4 attached. Reviewed by health econ team.
VI
Vikram IyerSat Oct 18, 2:15 PM
PRO data pull complete — 28 patients with EQ-5D-5L at week 7.
VI
Vikram IyerSat Oct 18, 2:40 PM
ICER white paper draft v1 — comments by Friday please.
KW
Karen WuSat Oct 18, 3:30 PM
RWE cohort n=60; durability extrapolation looks consistent.
VI
Vikram IyerTue Oct 21, 7:44 PM
Updated BIM v3 attached. Reviewed by health econ team.
SL
Sara LindqvistWed Oct 21, 8:43 PM
Updated BIM v2 attached. Reviewed by health econ team.
SL
Sara LindqvistWed Oct 22, 4:03 PM
NICE submission timeline locked. Module B due 6/15.
KW
Karen WuFri Oct 24, 4:17 PM
NICE submission timeline locked. Module B due 6/15.
VI
Vikram IyerSun Oct 25, 9:28 PM
ICER white paper draft v4 — comments by Friday please.
KW
Karen WuTue Oct 28, 5:41 PM
RWE cohort n=35; durability extrapolation looks consistent.
VI
Vikram IyerWed Oct 29, 7:53 PM
Module B drafted — sending for internal review.
KW
Karen WuFri Oct 31, 5:38 PM
ITC analysis vs Merck — final tables in the dossier folder.
SL
Sara LindqvistSun Nov 2, 3:13 PM
RWE cohort n=61; durability extrapolation looks consistent.
KW
Karen WuMon Nov 2, 8:55 PM
RWE cohort n=65; durability extrapolation looks consistent.
KW
Karen WuTue Nov 4, 3:13 PM
Module B drafted — sending for internal review.
SL
Sara LindqvistWed Nov 5, 3:17 PM
Cost-effectiveness model PSA convergence good at 67 runs.
VI
Vikram IyerWed Nov 5, 5:32 PM
Cost-effectiveness model PSA convergence good at 32 runs.
VI
Vikram IyerFri Nov 7, 5:22 PM
RWE cohort n=79; durability extrapolation looks consistent.
SL
Sara LindqvistSun Nov 8, 8:04 PM
ICER white paper draft v3 — comments by Friday please.
VI
Vikram IyerMon Nov 10, 2:46 PM
ITC analysis vs Merck — final tables in the dossier folder.
SL
Sara LindqvistTue Nov 11, 2:43 PM
ICER white paper draft v2 — comments by Friday please.
KW
Karen WuWed Nov 11, 8:56 PM
Module B drafted — sending for internal review.
KW
Karen WuWed Nov 12, 4:46 PM
Updated BIM v4 attached. Reviewed by health econ team.
VI
Vikram IyerThu Nov 12, 8:15 PM
PRO data pull complete — 44 patients with EQ-5D-5L at week 40.
SL
Sara LindqvistSat Nov 15, 12:18 PM
Engaged Optum data team on the Q3 pull.
SL
Sara LindqvistTue Nov 18, 5:09 PM
PRO data pull complete — 47 patients with EQ-5D-5L at week 81.
KW
Karen WuWed Nov 19, 4:27 PM
PRO data pull complete — 37 patients with EQ-5D-5L at week 4.
SL
Sara LindqvistThu Nov 20, 12:59 PM
Engaged Optum data team on the Q3 pull.
KW
Karen WuSat Nov 22, 4:40 PM
PRO data pull complete — 11 patients with EQ-5D-5L at week 67.
SL
Sara LindqvistSun Nov 22, 7:38 PM
Engaged Optum data team on the Q3 pull.
VI
Vikram IyerTue Nov 25, 5:22 PM
RWE cohort n=16; durability extrapolation looks consistent.
VI
Vikram IyerWed Nov 25, 7:59 PM
Updated BIM v6 attached. Reviewed by health econ team.
SL
Sara LindqvistThu Nov 27, 11:34 AM
ICER white paper draft v6 — comments by Friday please.
VI
Vikram IyerThu Nov 27, 12:16 PM
ITC analysis vs AstraZeneca — final tables in the dossier folder.
SL
Sara LindqvistThu Nov 27, 5:26 PM
Module B drafted — sending for internal review.
VI
Vikram IyerSat Nov 29, 11:40 AM
Module B drafted — sending for internal review.
VI
Vikram IyerWed Dec 3, 2:35 PM
NICE submission timeline locked. Module B due 6/15.
VI
Vikram IyerThu Dec 4, 3:27 PM
Cost-effectiveness model PSA convergence good at 74 runs.
VI
Vikram IyerThu Dec 4, 6:13 PM
Engaged Optum data team on the Q3 pull.
KW
Karen WuFri Dec 5, 3:04 PM
ITC analysis vs BMS — final tables in the dossier folder.
KW
Karen WuSat Dec 6, 11:49 AM
Updated BIM v4 attached. Reviewed by health econ team.
SL
Sara LindqvistSat Dec 6, 1:03 PM
Engaged Optum data team on the Q3 pull.
SL
Sara LindqvistFri Dec 11, 8:52 PM
Updated BIM v4 attached. Reviewed by health econ team.
KW
Karen WuFri Dec 12, 3:16 PM
Engaged Optum data team on the Q3 pull.
KW
Karen WuFri Dec 12, 3:42 PM
Engaged Optum data team on the Q3 pull.
SL
Sara LindqvistSat Dec 13, 1:37 PM
Cost-effectiveness model PSA convergence good at 74 runs.
KW
Karen WuFri Dec 19, 2:06 PM
ITC analysis vs Daiichi — final tables in the dossier folder.
KW
Karen WuSat Dec 20, 4:05 PM
ICER white paper draft v5 — comments by Friday please.
VI
Vikram IyerSat Dec 20, 5:42 PM
Updated BIM v4 attached. Reviewed by health econ team.
VI
Vikram IyerSat Dec 20, 6:42 PM
Cost-effectiveness model PSA convergence good at 63 runs.
SL
Sara LindqvistTue Dec 23, 2:25 PM
PRO data pull complete — 13 patients with EQ-5D-5L at week 40.
SL
Sara LindqvistThu Dec 25, 11:39 AM
NICE submission timeline locked. Module B due 6/15.
KW
Karen WuThu Dec 25, 3:31 PM
RWE cohort n=47; durability extrapolation looks consistent.
VI
Vikram IyerSat Dec 27, 11:50 AM
ITC analysis vs Roche — final tables in the dossier folder.
KW
Karen WuSun Dec 27, 7:39 PM
PRO data pull complete — 36 patients with EQ-5D-5L at week 4.
KW
Karen WuMon Dec 28, 8:35 PM
ICER white paper draft v1 — comments by Friday please.
KW
Karen WuWed Dec 30, 7:30 PM
Engaged Optum data team on the Q4 pull.
VI
Vikram IyerWed Dec 30, 8:29 PM
Cost-effectiveness model PSA convergence good at 80 runs.
VI
Vikram IyerThu Jan 1, 12:08 PM
PRO data pull complete — 27 patients with EQ-5D-5L at week 32.
VI
Vikram IyerThu Jan 1, 12:16 PM
NICE submission timeline locked. Module B due 6/15.
KW
Karen WuFri Jan 2, 6:11 PM
Module B drafted — sending for internal review.
SL
Sara LindqvistTue Jan 6, 6:58 PM
NICE submission timeline locked. Module B due 6/15.
KW
Karen WuThu Jan 8, 2:30 PM
RWE cohort n=44; durability extrapolation looks consistent.
KW
Karen WuThu Jan 8, 3:27 PM
ITC analysis vs BMS — final tables in the dossier folder.
SL
Sara LindqvistFri Jan 9, 11:45 AM
NICE submission timeline locked. Module B due 6/15.
SL
Sara LindqvistSun Jan 10, 7:25 PM
Cost-effectiveness model PSA convergence good at 44 runs.
VI
Vikram IyerTue Jan 13, 11:53 AM
Updated BIM v4 attached. Reviewed by health econ team.
SL
Sara LindqvistTue Jan 13, 4:55 PM
Module B drafted — sending for internal review.
KW
Karen WuThu Jan 15, 2:50 PM
Module B drafted — sending for internal review.
VI
Vikram IyerFri Jan 16, 3:58 PM
Cost-effectiveness model PSA convergence good at 38 runs.
SL
Sara LindqvistSat Jan 17, 1:34 PM
RWE cohort n=34; durability extrapolation looks consistent.
SL
Sara LindqvistSun Jan 17, 7:32 PM
Health-econ team meeting moved to Thursday.
KW
Karen WuTue Jan 20, 11:48 AM
Engaged Optum data team on the Q4 pull.
KW
Karen WuTue Jan 20, 3:25 PM
NICE submission timeline locked. Module B due 6/15.
KW
Karen WuTue Jan 20, 3:48 PM
RWE cohort n=75; durability extrapolation looks consistent.
KW
Karen WuTue Jan 20, 3:49 PM
Cost-effectiveness model PSA convergence good at 20 runs.
VI
Vikram IyerThu Jan 22, 1:09 PM
Engaged Optum data team on the Q4 pull.
VI
Vikram IyerFri Jan 23, 3:15 PM
ITC analysis vs Merck — final tables in the dossier folder.
SL
Sara LindqvistTue Jan 27, 4:53 PM
Updated BIM v4 attached. Reviewed by health econ team.
VI
Vikram IyerTue Jan 27, 5:02 PM
Engaged Optum data team on the Q4 pull.
KW
Karen WuThu Jan 29, 1:34 PM
ICER white paper draft v5 — comments by Friday please.
VI
Vikram IyerFri Jan 30, 11:27 AM
PRO data pull complete — 11 patients with EQ-5D-5L at week 47.
KW
Karen WuSat Jan 31, 11:27 AM
Updated BIM v6 attached. Reviewed by health econ team.
VI
Vikram IyerSun Jan 31, 7:39 PM
ITC analysis vs Roche — final tables in the dossier folder.
VI
Vikram IyerTue Feb 3, 11:26 AM
Updated BIM v4 attached. Reviewed by health econ team.
VI
Vikram IyerWed Feb 4, 3:15 PM
ICER white paper draft v6 — comments by Friday please.
VI
Vikram IyerThu Feb 4, 7:40 PM
RWE cohort n=11; durability extrapolation looks consistent.
VI
Vikram IyerMon Feb 9, 4:39 PM
Updated BIM v4 attached. Reviewed by health econ team.
VI
Vikram IyerWed Feb 10, 7:04 PM
Module B drafted — sending for internal review.
KW
Karen WuThu Feb 12, 3:39 PM
ICER white paper draft v2 — comments by Friday please.
KW
Karen WuFri Feb 13, 12:24 PM
Module B drafted — sending for internal review.
SL
Sara LindqvistFri Feb 13, 5:13 PM
RWE cohort n=75; durability extrapolation looks consistent.
VI
Vikram IyerSun Feb 14, 7:14 PM
Updated BIM v1 attached. Reviewed by health econ team.
KW
Karen WuTue Feb 17, 2:37 PM
RWE cohort n=42; durability extrapolation looks consistent.
VI
Vikram IyerWed Feb 17, 8:26 PM
ICER white paper draft v2 — comments by Friday please.
KW
Karen WuWed Feb 18, 11:01 AM
Engaged Optum data team on the Q4 pull.
KW
Karen WuThu Feb 19, 2:50 PM
Cost-effectiveness model PSA convergence good at 66 runs.
SL
Sara LindqvistSat Feb 21, 3:16 PM
PRO data pull complete — 58 patients with EQ-5D-5L at week 32.
SL
Sara LindqvistWed Feb 24, 8:04 PM
PRO data pull complete — 52 patients with EQ-5D-5L at week 32.
VI
Vikram IyerWed Feb 25, 4:52 PM
Cost-effectiveness model PSA convergence good at 46 runs.
SL
Sara LindqvistThu Feb 26, 11:39 AM
NICE submission timeline locked. Module B due 6/15.
KW
Karen WuTue Mar 2, 7:37 PM
Health-econ team meeting moved to Thursday.
VI
Vikram IyerTue Mar 2, 8:37 PM
RWE cohort n=39; durability extrapolation looks consistent.
VI
Vikram IyerTue Mar 3, 11:47 AM
NICE submission timeline locked. Module B due 6/15.
VI
Vikram IyerWed Mar 4, 11:18 AM
RWE cohort n=10; durability extrapolation looks consistent.
KW
Karen WuThu Mar 5, 1:19 PM
Health-econ team meeting moved to Thursday.
KW
Karen WuThu Mar 5, 5:17 PM
NICE submission timeline locked. Module B due 6/15.
VI
Vikram IyerFri Mar 5, 8:38 PM
Updated BIM v4 attached. Reviewed by health econ team.
KW
Karen WuTue Mar 10, 3:02 PM
Cost-effectiveness model PSA convergence good at 37 runs.
SL
Sara LindqvistWed Mar 11, 5:47 PM
ITC analysis vs Roche — final tables in the dossier folder.
KW
Karen WuSat Mar 13, 8:26 PM
Updated BIM v6 attached. Reviewed by health econ team.
SL
Sara LindqvistSat Mar 14, 4:49 PM
Health-econ team meeting moved to Thursday.
SL
Sara LindqvistTue Mar 17, 2:19 PM
ITC analysis vs Daiichi — final tables in the dossier folder.
VI
Vikram IyerTue Mar 17, 4:47 PM
Updated BIM v3 attached. Reviewed by health econ team.
VI
Vikram IyerThu Mar 18, 9:39 PM
ITC analysis vs Daiichi — final tables in the dossier folder.
VI
Vikram IyerFri Mar 20, 6:46 PM
Cost-effectiveness model PSA convergence good at 49 runs.
SL
Sara LindqvistSat Mar 21, 4:34 PM
RWE cohort n=43; durability extrapolation looks consistent.
VI
Vikram IyerTue Mar 24, 6:24 PM
ITC analysis vs AstraZeneca — final tables in the dossier folder.
VI
Vikram IyerWed Mar 25, 6:58 PM
ITC analysis vs BMS — final tables in the dossier folder.
VI
Vikram IyerSat Mar 27, 8:11 PM
PRO data pull complete — 63 patients with EQ-5D-5L at week 48.
SL
Sara LindqvistSat Mar 28, 4:32 PM
Health-econ team meeting moved to Thursday.
SL
Sara LindqvistSun Mar 29, 5:38 PM
Updated BIM v4 attached. Reviewed by health econ team.
VI
Vikram IyerTue Mar 31, 1:57 PM
Updated BIM v4 attached. Reviewed by health econ team.
KW
Karen WuTue Mar 31, 5:52 PM
ITC analysis vs BMS — final tables in the dossier folder.
KW
Karen WuThu Apr 2, 7:02 PM
ICER white paper draft v5 — comments by Friday please.
KW
Karen WuFri Apr 2, 9:44 PM
Updated BIM v1 attached. Reviewed by health econ team.
KW
Karen WuTue Apr 7, 12:58 PM
NICE submission timeline locked. Module B due 6/15.
VI
Vikram IyerWed Apr 8, 4:06 PM
Cost-effectiveness model PSA convergence good at 5 runs.
KW
Karen WuWed Apr 8, 5:40 PM
ITC analysis vs Daiichi — final tables in the dossier folder.
SL
Sara LindqvistFri Apr 10, 5:22 PM
Engaged Optum data team on the Q5 pull.
VI
Vikram IyerThu Apr 15, 9:33 PM
NICE submission timeline locked. Module B due 6/15.
VI
Vikram IyerThu Apr 16, 2:09 PM
ITC analysis vs BMS — final tables in the dossier folder.
SL
Sara LindqvistMon Apr 20, 3:06 PM
Health-econ team meeting moved to Thursday.
SL
Sara LindqvistMon Apr 20, 7:42 PM
Cost-effectiveness model PSA convergence good at 30 runs.
KW
Karen WuTue Apr 21, 1:25 PM
Cost-effectiveness model PSA convergence good at 82 runs.
VI
Vikram IyerWed Apr 22, 5:12 PM
Updated BIM v4 attached. Reviewed by health econ team.
VI
Vikram IyerThu Apr 23, 2:20 PM
RWE cohort n=83; durability extrapolation looks consistent.
KW
Karen WuThu Apr 23, 6:01 PM
ITC analysis vs Merck — final tables in the dossier folder.
KW
Karen WuTue Apr 28, 6:33 PM
Updated BIM v6 attached. Reviewed by health econ team.
SL
Sara LindqvistFri May 1, 12:51 PM
Engaged Optum data team on the Q5 pull.
VI
Vikram IyerSat May 2, 2:46 PM
Cost-effectiveness model PSA convergence good at 20 runs.
SL
Sara LindqvistMon May 4, 6:35 PM
Updated BIM v4 attached. Reviewed by health econ team.
KW
Karen WuTue May 5, 6:52 PM
Updated BIM v1 attached. Reviewed by health econ team.
SL
Sara LindqvistWed May 6, 11:00 AMarc: nice-veltarix
NICE submission timeline locked. Module B due 6/15. — NICE STA submission window opens June 2026; ICER threshold strategy assumes £28k/QALY base case.
↗ NICE requirements↗ NICE STA Submission Plan doc
VI
Vikram IyerWed May 6, 2:49 PM
PRO data pull complete — 23 patients with EQ-5D-5L at week 32.
VI
Vikram IyerSat May 9, 12:33 PM
ICER white paper draft v1 — comments by Friday please.
VI
Vikram IyerSat May 9, 1:24 PM
Module B drafted — sending for internal review.
SL
Sara LindqvistSun May 9, 8:43 PM
Module B drafted — sending for internal review.
SL
Sara LindqvistWed May 12, 8:04 PM
Module B drafted — sending for internal review.
KW
Karen WuWed May 12, 9:38 PM
Engaged Optum data team on the Q5 pull.
SL
Sara LindqvistFri May 15, 9:00 AMarc: nice-veltarix
T-109 days to NICE STA submission for Veltarix (2026-09-01). 4 blocker gaps remain. — Friday gap-review: biggest open item is the long-term durability extrapolation — health-econ team estimates 14 months to close, so we either re-scope the submission or accept the risk. Need a call Monday.
↗ NICE gap report
VI
Vikram IyerSun May 17, 3:32 PM
ICER white paper draft v4 — comments by Friday please.
SL
Sara LindqvistMon May 18, 1:04 PM
ICER white paper draft v4 — comments by Friday please.
KW
Karen WuMon May 18, 5:37 PM
PRO data pull complete — 9 patients with EQ-5D-5L at week 84.
KW
Karen WuWed May 20, 3:38 PM
Engaged Optum data team on the Q5 pull.
SL
Sara LindqvistWed May 20, 5:50 PM
Engaged Optum data team on the Q5 pull.
KW
Karen WuThu May 21, 12:42 PM
Module B drafted — sending for internal review.
VI
Vikram IyerThu May 21, 2:53 PM
Updated BIM v6 attached. Reviewed by health econ team.
SL
Sara LindqvistFri May 22, 2:27 PM
PRO data pull complete — 83 patients with EQ-5D-5L at week 65.
KW
Karen WuMon May 25, 6:18 PM
Cost-effectiveness model PSA convergence good at 19 runs.
SL
Sara LindqvistTue May 26, 4:20 PM
Updated BIM v2 attached. Reviewed by health econ team.
SL
Sara LindqvistWed May 27, 1:22 PM
Cost-effectiveness model PSA convergence good at 49 runs.
KW
Karen WuThu May 27, 9:51 PM
RWE cohort n=45; durability extrapolation looks consistent.
KW
Karen WuThu May 28, 7:19 PM
ITC analysis vs Daiichi — final tables in the dossier folder.
KW
Karen WuFri May 29, 6:13 PM
Health-econ team meeting moved to Thursday.
KW
Karen WuTue Jun 2, 6:49 PM
ITC analysis vs Daiichi — final tables in the dossier folder.
KW
Karen WuThu Jun 4, 4:12 PM
Engaged Optum data team on the Q5 pull.
SL
Sara LindqvistSat Jun 5, 8:03 PM
ICER white paper draft v1 — comments by Friday please.
SL
Sara LindqvistSat Jun 6, 1:09 PM
Module B drafted — sending for internal review.
KW
Karen WuSat Jun 6, 1:24 PM
ITC analysis vs BMS — final tables in the dossier folder.
VI
Vikram IyerSun Jun 7, 2:51 PM
RWE cohort n=78; durability extrapolation looks consistent.
KW
Karen WuTue Jun 9, 12:55 PM
Module B drafted — sending for internal review.
VI
Vikram IyerFri Jun 12, 1:17 PM
Updated BIM v4 attached. Reviewed by health econ team.
VI
Vikram IyerFri Jun 12, 7:34 PM
Engaged Optum data team on the Q5 pull.
VI
Vikram IyerSat Jun 13, 3:45 PM
ITC analysis vs Roche — final tables in the dossier folder.
SL
Sara LindqvistTue Jun 16, 3:03 PM
NICE submission timeline locked. Module B due 6/15.
KW
Karen WuTue Jun 16, 3:11 PM
ITC analysis vs Merck — final tables in the dossier folder.
SL
Sara LindqvistThu Jun 17, 8:47 PM
PRO data pull complete — 70 patients with EQ-5D-5L at week 72.
VI
Vikram IyerThu Jun 17, 9:03 PM
Updated BIM v4 attached. Reviewed by health econ team.
SL
Sara LindqvistSun Jun 20, 9:30 PM
Updated BIM v1 attached. Reviewed by health econ team.